Corporate Update

By

Regulatory News | 04 Nov, 2020

Updated : 07:02

RNS Number : 1632E
Alpha Growth PLC
04 November 2020
 

Alpha Growth Plc

("Alpha", or the "Company")

Corporate Update

 

Alpha Growth Plc (LSE: ALGW), the financial services specialist in the growing Senior Life Settlement ("SLS") asset class is pleased to provide the market with a corporate update on the Company's business. This release provides an update on the Impact of Covid-19 and addresses shareholder questions that the Company has received since its last update.

 

The Company's fiscal year ended on 31 August 2020 with the audited accounts expected to be released in December. As expected, the Company generated its first revenues, albeit a modest amount, through its fund management activity. This initial revenue generation was a milestone that was eagerly passed and continues to be built upon.

 

The significant activity the past few months has been the focus on marketing the BlackOak Alpha Growth Fund (the "Fund"). We are pleased to report that the AUM in the Fund has been doubled to approximately $20 million. In the month of October alone $7.6 million of subscriptions were received. The increase in AUM builds upon itself as the Fund will become eligible to investors who seek to invest a meaningful amount but do not want to hold, or cannot hold for internal or regulatory reasons more than a certain percentage of the overall AUM.

 

We continue to market to registered investment advisors and experience higher open, click, and reply rates for email campaigns. These translate into introductory conference calls, due diligence reviews, and so on.  The subscriptions in October into the Fund were the result of this process and excellent client service.

 

The Fund continues to perform well and is on course to provide a return within the 10% to 14% target range.  For the months of August and September the returns were 1.82% and 1.42% respectively.  We will continue to build strength on strength.

 

The Company's discussion with the Warehouse Loan/Short Term Credit Facility counterparty continues and is nearing a conclusive step. The counterparty's COVID policy is limiting their ability to conclude site visits to the Company's and our servicing agents' US based offices. The Company will provide further updates as discussions progress.

 

The Company has begun its promotion of the Alpha Growth & Income ("AGI") strategy. As previously announced, this strategy is a combination of life settlements and life contingent structured settlements hedged by a life insurance policy that is suitable for investors seeking cashflow and growth, funded in either a separate managed account or as a co-mingled fund with a minimum investment of $50 million.  The AGI can provide the investor an annual cash flow through the structured settlement asset and growth in the principal invested through the life settlement asset. The Company will provide further updates as discussions merit an announcement.

 

The impact of Covid-19 has no doubt influenced the timing of various counterparties to transact with the Company. Over the past few months, it is evident that the management of the pandemic by various Governments is unpredictable and impacts the movement of individuals. In addition, the internal policies of counterparties pose some hurdles to concluding transactions in a timely fashion.

 

The Company works with European, UK, and USA counterparties. A number of European and UK investors are stalled in their abilities to conduct business as before and adjusting to new ways of complying with their internal requirements for completing due diligence and progressing analysis with a dispersed workforce. This no doubt affects the ability of the Company to increase assets under management.

 

As life settlements are uniquely a US based asset, the Company is allocating more time to prospective clients for its strategies in the USA, allowing for in person meetings, which has produced results for the Fund. The Company's CEO, Gobind Sahney, comments that "since July, I have travelled every month for meetings in New York, Florida, and Texas and continue to schedule meetings with US investors that are open to meeting." 

 

On an operational level, the Company continues to maintain a lean operating structure and sufficient working capital for its strategies. We are also pleased to announce the launch of our new website www.algwplc.com which is truly reflective of the professional and contemporary nature of the Company. The new website was influenced through shareholder input.  In addition we launched a stand alone website for the Fund at www.BOAGF.com. The Fund's website continues the look, branding, and provides functionality for clients to access documents and other information through a password protected format.

 

Going into the future the 2021 outlook is positive. At the conclusion of the US elections, whoever is the winner, the Company is still confident that, particularly with record low interest rates, continued volatility in the equity markets and the non-correlation of SLS assets, it will be able to continue its strategies, and also take advantage of further opportunities as and when they arise in the longevity asset sector..

 

As previously stated, the continued impact of Covid19 policies are unpredictable and there will be an impact on Company's financial results if delays continue for an extended period of time. However, the Company's executives continue to allocate time to what they can control in order to build on the Company's progress.

 

The Directors thank the shareholders for their continuing support and look forward to making progress on all strategies in as timely a manner as possible.  Further details are provided on the Company website www.algwplc.com.

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

For more information, please visit www.algwplc.com or contact the following:

Alpha Growth Plc

+44 (0) 20 3959 8600

Gobind Sahney, Executive Chairman 

info@algwplc.com



Pello Capital Limited

+44 (0) 20 7710 9610

Mark Treharne

mt@pellocapital.com

 

Alpha Growth Plc: Gobind Sahney, Executive Chairman +44 (0) 20 3959 8600 info@algwplc.com

 

About Alpha Growth Plc

Specialist in Longevity Assets

Alpha Growth Plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, the Alpha Growth Group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

 

SLS Assets and Non-correlation

A SLS refers to the sale of an existing life insurance policy to a third party for a cash payment. Such a payment will be in excess of the policy's surrender value, but less than its face value. After the sale, the purchaser becomes the policy's beneficiary and assumes payment of its premiums. There are many reasons why policy holders may choose to sell their life insurance policies and sales are usually only undertaken when the insured person doesn't have a known life-threatening illness. The SLS provides individuals with policies the option to realise value from an asset under a regulated transaction. As a longevity asset, the SLS is non-correlated to the real estate, equity capital and commodity markets.  Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.

 

Note: The Company only advises on and manages SLS Assets that originate in the USA where the SLS market is highly regulated.

 

Forward Looking Statements Disclaimer

Certain statements, beliefs and opinions in this document are forward-looking, which reflect the Company's or, as appropriate, the Company's directors' current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this document regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward- looking statements, which speak only as of the date of this document.  Readers should not treat the contents of this document as advice relating to legal, taxation or investment matters, and are to make their own assessments concerning these and other consequences, including the merits of information and the risks.  Readers of this announcement are advised to conduct their own due diligence and agree to be bound by the limitations of this disclaimer.

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDKKNBBDBDBFDK

Last news